China Securities Regulatory Commission, Compilation Rules for Information Disclosures by Companies That Offer Securities to the Public No. 25: Guidelines for the Content and Format of Prospectuses of Companies That Engage in Pharmaceutical and Medical Device Business

中国证券监督管理委员会公开发行证券的公司信息披露编报规则第25号——从事药品及医疗器械业务的公司招股说明书内容与格式指引

CSRC sets forth disclosure requirements for listed pharma companies.

3 minute readAugust 19, 2022 at 05:50 AM
By
Susan Mok

Issued: July 29, 2022

Effective: as of date of issuance

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

  • ✓ A database of 3000+ essential documents, including key PRC laws translated into English
  • ✓ Newsletters with business-critical and sector-specific updates
  • ✓ Premium mobile access with timely analysis on China's fast-changing market

Already a Subscriber? Log In. Sign In Now

Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)